Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer

摘要

Compounds that inhibit protein kinases such as Aurora-kinases and the VEGFR and PDGFR families of kinases, with an improved safety profile due to low CYP3A4 inhibition, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.